This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and
universities.
| Rule |
Rule 4731-17-01 | Definitions.
For purposes of this chapter of the Administrative
Code: (A) "Licensee" means any person
holding or practicing pursuant to a certificate issued by the board under
Chapter 4730., 4731., 4760., 4761., 4762., or 4774. of the Revised
Code. (B) "Invasive procedure" means
any of the following: (1) Surgical or
procedural entry into tissues, cavities, or organs or repair of major traumatic
injuries associated with any of the following: an operating or delivery room,
emergency department, or outpatient setting, including physicians'
offices; cardiac catheterization and angiographic procedures; a vaginal or
cesarean delivery or other invasive obstetric procedure during which bleeding
may occur; or the manipulation, cutting, or removal of any oral or perioral
tissues, including tooth structure, during which bleeding occurs or the
potential for bleeding exists. (2) Any entry into the
hair follicle using an electric modality for the purpose of hair
removal. (3) The practice of
acupuncture as defined in section 4762.01 of the Revised Code. (4) The performance of
fluoroscopic procedures pursuant to section 4774.08 of the Revised
Code. (5) The performance of
cosmetic procedures, such as the injection of botulinum toxin, dermal fillers,
permanent makeup at a location that is not licensed under the rules in Chapter
3701-9 of the Administrative Code, laser hair removal, and hair replacement
procedures. (6) The performance of
respiratory care procedures involving blood and gas sampling, administering
medical gases, aerosols and medications, performing aspiration, and the use of
artificial airways, ventilators and other life support equipment. (C) "FDA" means the United
States food and drug administration. (D) "EPA" means the United
States environmental protection agency.
Last updated June 1, 2021 at 8:52 AM
|
Rule 4731-17-02 | Universal precautions.
Effective:
November 30, 2016
Licensees who perform or participate in invasive
procedures shall, in the performance of or participation in any such procedures
or functions, be familiar with, observe and rigorously adhere to the acceptable
and prevailing standards for universal blood and body fluid precautions to
minimize the risk of being exposed to or exposing others to the hepatitis B
virus (HBV), the hepatitis C virus (HCV), and the human immunodeficiency virus
(HIV). The acceptable and prevailing universal blood and body fluid precautions
which the licensee follows shall include at least the following: (A) Appropriate use of hand
washing; (B) Effective disinfection and
sterilization of equipment; (C) Safe handling and disposal of needles
and other sharp instruments; and (D) Appropriate barrier techniques
including wearing and disposal of gloves and other protective garments and
devices.
Last updated February 28, 2023 at 1:04 PM
|
Rule 4731-17-03 | Hand washing.
Effective:
February 28, 2004
Licensees who perform or participate in invasive procedures shall follow acceptable and prevailing standards for hand washing which shall include at least the following: (A) Hands shall be washed appropriately prior to performing or participating in an invasive procedure and after performing or participating in an invasive procedure; (B) Hands and other skin surfaces shall be washed immediately and thoroughly if contaminated with blood or other body fluids; and (C) Hands shall be washed immediately after gloves are removed.
Last updated February 28, 2023 at 1:05 PM
|
Rule 4731-17-04 | Disinfection and sterilization.
Instruments and other equipment classified by the
FDA as reusable, used by licensees who perform or participate in invasive
procedures shall be appropriately disinfected and sterilized according to
acceptable and prevailing standards for disinfection and sterilization which
shall include at least the following: (A) Instruments and devices that enter
the patient's vascular system or other normally sterile areas of the body
shall be sterilized before being used for each patient; (B) Instruments and devices that touch
intact mucous membranes but do not penetrate the patient's body surfaces
shall be sterilized when possible, or undergo high-level disinfection if they
cannot be sterilized before using for each patient; (C) Instruments and devices that are
able to withstand repeated exposure to heat shall be heat sterilized.
Sterilization shall be accomplished by autoclave, dry heat, unsaturated
chemical vapor, ethylene oxide, hydrogen peroxide gas plasma, or any other
FDA/EPA-approved method; (D) Instruments and items that cannot
withstand heat sterilization shall be subjected to a high level disinfection
process, including compliance with any manufacturer's instructions for
disinfection; (E) Heat sterilizing devices shall be
tested for proper function on a weekly basis by means of a biological
monitoring system that indicates microorganism kill. Documentation shall be
maintained either in the form of a log reflecting dates and person(s)
conducting the testing or copies of reports from an independent testing entity.
The documentation shall be maintained for a period of at least two years. In
the event of a positive biological spore test, the licensee must take immediate
remedial action to ensure that heat sterilization is being
accomplished; (F) Surface disinfection: (1) Environmental
surfaces that are contaminated by blood or other body fluids shall be
disinfected with a chemical germicide that is registered with the environmental
protection agency as a "hospital disinfectant" or sodium hypochlorite
and is mycobactericidal at use-dilution. The disinfection process shall be
followed before each patient; and (2) Impervious backed
paper, aluminum foil or plastic wrap shall be used to cover surfaces that may
be contaminated by blood or other body fluids and that are difficult or
impossible to disinfect. The cover shall be removed, discarded and then
replaced between patients. (G) Single use items used in treating a
patient, which have become contaminated by blood or other body fluids, shall be
discarded and not reused, unless sterilized and reused in accordance with
current guidelines established by the FDA. Single use items being reused in
treating a patient shall be adequately cleaned and sterilized. Single use items
shall not be reused if the items' physical characteristics and quality
have been adversely affected or if the items are incapable of being reused
safely and effectively for their intended use.
Last updated June 1, 2021 at 8:53 AM
|
Rule 4731-17-05 | Handling and disposal of sharps and wastes.
(A) To prevent injuries, no licensee
performing or participating in invasive procedures shall recap needles, or
purposely bend or break needles or other sharp instruments or items by
hand. (B) After a licensee who is performing or
participating in an invasive procedure uses disposable needles, syringes,
scalpel blades or other sharp items, the licensee shall place the disposable
sharp items used in a puncture-resistant container for disposal. The
puncture-resistant container shall be located as close as practicable to the
use area. (C) All sharp items and contaminated
wastes shall be disposed of according to requirements established by federal,
local and state environmental or regulatory agencies.
Last updated June 1, 2021 at 8:53 AM
|
Rule 4731-17-06 | Barrier techniques.
Effective:
February 28, 2004
All licensees who perform or participate in invasive procedures shall routinely use appropriate barrier precautions to prevent skin and mucous-membrane contact with blood and other body fluids of all patients. The barrier techniques to be followed are: (A) All licensees shall wear disposable gloves when performing or participating in invasive procedures. Hands shall be washed when gloves are removed. Before performing or participating in invasive procedures on another patient, the licensee shall wash hands and reglove with another pair of disposable gloves. If a glove is torn or a needlestick or other injury occurs, the glove shall be removed and a new glove used as promptly as patient safety permits. The needle or instrument involved in the incident shall be removed from the sterile field. Disposable gloves shall not be washed or reused for any purpose. (B) All licensees shall wear masks and protective eyewear when performing or participating in invasive procedures if during the procedure there is likely to be spattering or splashing of blood or other body fluids. (C) Gowns or aprons made of materials that provide an effective barrier shall be worn by all licensees who are performing or participating in invasive procedures if during the procedure there is likely to be spattering or splashing of blood or other body fluids.
Last updated February 28, 2023 at 1:05 PM
|
Rule 4731-17-07 | Violations.
(A) A physician assistant who violates
any provision of this chapter shall be subject to discipline pursuant to
divisions (B)(2), (B)(3), (B)(19) and (B)(21) of section 4730.25 of the Revised
Code. (B) An anesthesiologist assistant who
violates any provision of this chapter shall be subject to discipline pursuant
to divisions (B)(2), (B)(3), (B)(4) and (B)(19) of section 4760.13 of the
Revised Code. (C) An acupuncturist who violates any
provision of this chapter shall be subject to discipline pursuant to divisions
(B)(2), (B)(3), (B)(4) and (B)(20) of section 4762.13 of the Revised
Code. (D) A radiologist assistant who violates
any provision of this chapter shall be subject to discipline pursuant to
divisions (B)(2), (B)(3), (B)(4), and (B)(19) of section 4774.13 of the Revised
Code. (E) Any other licensee who violates any
provision of this chapter shall be subject to discipline pursuant to divisions
(B)(6), (B)(20) and (B)(29) of section 4731.22 of the Revised
Code. (F) A respiratory care professional or
limited permit holder who violates any provision of this chapter shall be
subject to discipline pursuant to division (B)(10) of section 4761.09 of the
Revised Code.
Last updated June 1, 2021 at 8:53 AM
|
